Drugs / FloSeal Matrix
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00742313 | Jun 2009 → Sep 2012 | hemorrhagic disease | Duke University | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FloSeal Matrix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00742313 ↗ |